Cargando…

Hodgkin's variant of Richter transformation during ibrutinib therapy: A case report and review of the literature

Hodgkin's variant of Richter transformation is a rare complication of chronic lymphocytic leukemia and is associated with inferior outcomes compared to de novo Hodgkin lymphoma. Further data concerning prognosis and treatment of Hodgkin's variant of Richter transformation occurring in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afonso, Carolina, Gomes, Marília, Pereira, Marta Isabel, Faria, Carlos, Pina, Raquel, Saraiva, Tiago, Geraldes, Catarina, Carda, José Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529751/ https://www.ncbi.nlm.nih.gov/pubmed/36225619 http://dx.doi.org/10.1002/ccr3.6136

Ejemplares similares

P014: Prognostic significance of nutritional indexes (CONUT and PNI) in classical Hodgkin lymphoma patients
por: Sousa, Rita Costa E., et al.
Publicado: (2022)

P011: IPS-7 or IPS-3 to identify very-high risk patients in advanced Classical Hodgkin’s Lymphoma: Which score to choose
por: Almeida, Cátia, et al.
Publicado: (2022)

Ibrutinib has some activity in Richter's syndrome
por: Giri, S, et al.
Publicado: (2015)

Rare Richter Transformation of Chronic Lymphocytic Lymphoma to Hodgkin Lymphoma
por: Buckley, Tinera, et al.
Publicado: (2021)

Ibrutinib and rituximab induced rapid response in refractory Richter syndrome
por: Lamar, Zanetta, et al.
Publicado: (2015)

Hodgkin Variant of Richter’s Transformation in Chronic Lymphocytic Leukemia (CLL): An Illustrative Case Report and Literature Review
por: Gupta, Nishit, et al.
Publicado: (2021)

An experience with ibrutinib monotherapy for Richter’s syndrome isolated in the central nervous system
por: Nato, Yuma, et al.
Publicado: (2022)

PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING?
por: Moura, Pedro, et al.
Publicado: (2023)

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
por: Hodkinson, Brendan P., et al.
Publicado: (2020)

A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
por: Jain, Nitin, et al.
Publicado: (2022)

Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature
por: JANJETOVIC, SNJEZANA, et al.
Publicado: (2016)

Biology and Treatment of Richter Transformation
por: Condoluci, Adalgisa, et al.
Publicado: (2022)

Cytogenomic features of Richter transformation
por: Woroniecka, Renata, et al.
Publicado: (2023)

Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant
por: Master, Samip, et al.
Publicado: (2017)

PB1881: IBRUTINIB REDUCES THE RISK OF RICHTER’S TRANSFORMATION IN PREVIOUSLY TREATED CLL PATIENTS: A POPULATION-BASED STUDY IN BRITISH COLUMBIA
por: Ramadan, R., et al.
Publicado: (2022)

Richter Transformation: Clinical Manifestations, Evaluation, and Management
por: Douglas, Melanie
Publicado: (2022)

An Approach to Diagnosis of Richter Transformation in Chronic Lymphocytic Leukemia
por: Broadway-Duren, Jackie
Publicado: (2022)

Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
por: Nadeu, Ferran, et al.
Publicado: (2022)

A Rare Cause of Cavitary Lesion in the Lung: Richter's Transformation
por: Yıldırım, Fatma, et al.
Publicado: (2015)

U-RT1 – A new model for Richter transformation
por: Schmid, Teresa, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation outcomes in patients with Richter’s transformation
por: Kim, Haesook T., et al.
Publicado: (2021)

Vitamin D poisoning; hypercalcemia in a case with richter transformation
por: Biberoğlu, Serap, et al.
Publicado: (2021)

Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era
por: Briski, Robert, et al.
Publicado: (2023)

Sviatoslav Richter
Publicado: (1998)

Sviatoslav Richter.
por: Beethoven, Ludwig van, 1770-1827
Publicado: (1998)

Richter Syndrome
por: Condoluci, Adalgisa, et al.
Publicado: (2021)

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
por: Fabbri, Giulia, et al.
Publicado: (2013)

Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia
por: El-Haj, Nura, et al.
Publicado: (2014)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
por: Tadmor, Tamar, et al.
Publicado: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

Richter transformation with marked plasmacytic differentiation, mimicking plasma cell neoplasm
por: Li, Shaoying, et al.
Publicado: (2022)

Honouring Burton Richter
Publicado: (2000)

The psychobiology of Curt Richter
Publicado: (1977)

Periorbital Richter Syndrome
por: Gorman, Mark, et al.
Publicado: (2015)

Hypercalcemia in Small Lymphocytic Lymphoma with an Elevated Parathyroid Hormone-Related Peptide Associated with Early Richter Transformation
por: Bains, Ashish, et al.
Publicado: (2021)

Methotrexate-Associated Lymphoproliferative Disorder in a Patient with Psoriasis: A Case Report and Review of the Literature
por: Afonso, Carolina, et al.
Publicado: (2022)

A Carotid Body Tumour Mimicking Richter’s Transformation of Chronic Lymphocytic Leukaemia
por: Qamar, Younus, et al.
Publicado: (2022)

Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia
por: Tam, Constantine, et al.
Publicado: (2023)

Early Transformation to Classic Hodgkin Lymphoma in a Chemotherapy-naïve Chronic Lymphocytic Leukemia Patient upon Initial Treatment with Ibrutinib
por: Koshiishi, Megumi, et al.
Publicado: (2021)

Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
por: Lindholm, Kaleigh E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b4mclg8lvb0mqo1dn8ejincois